EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats



Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats



Fundamental and Applied Toxicology 30(2): 220-228



The incidence of Leydig cell adenomas increases in CD rats fed for 2 years with the hepatic peroxisome proliferator, ammonium perfluorooctanoate (C8). Treatment with C8 increased the serum concentration of estradiol in 2-week gavage studies, and feeding studies at various time points up to 2 years, and was also accompanied by increases in liver weight and hepatic beta-oxidation activity. Since peroxisome proliferators induce both hepatic beta-oxidation and specific cytochrome P450 enzymes, C8 may also induce aromatase (cytochrome P450-19A1), the cytochrome P450 monooxygenase which converts androgens to estrogens. This hypothesis was investigated in the present study. Adult male CD rats were dosed daily by gavage for 14 days with 0, 0.2, 2, 20, or 40 mg C8/kg body wt. An additional group, the pair-fed control, was fed at a rate matched to the daily consumption by the 40 mg C8/kg group. Treatment with C8 produced a dose-dependent decrease in body weight, and increases in absolute and relative liver weights, and in the protein yield of hepatic microsomes. These C8-induced changes were associated with a 2-fold increase in the serum concentration of estradiol and up to a 16-fold increase in total hepatic aromatase activity. A significant linear correlation was established between serum estradiol and total hepatic aromatase activity. The absolute weights and the aromatase activity of the testes were not affected by C8. Hepatic peroxisomal beta-oxidation activity and the microsomal concentration of total cytochrome P450 were also increased by C8. A comparison of estimated EC50 values suggested that these parameters may be less sensitive to induction by C8 than hepatic aromatase activity. Co-incubation of control liver microsomes with C8 in the aromatase assay for 2 hr dose dependently reduced the apparent aromatase activity. This inhibition of aromatase in vitro but increase in vivo was further investigated using cultured rat hepatocytes. Decreases in aromatase activity were found after up to 42 hr of treatment with C8, but the enzyme activity was increased almost 2-fold after 66 hr. The results of this study suggest that the increased serum concentration of estradiol produced by C8 in rats is at least partly due to a direct effect on the liver to increase synthesis of estradiol through induction of aromatase cytochrome P450 in the endoplasmic reticulum.

(PDF emailed within 0-6 h: $19.90)

Accession: 008549567

Download citation: RISBibTeXText

PMID: 8812269

DOI: 10.1006/faat.1996.0059



Related references

Effect of the peroxisome proliferator, ammonium perfluorooctanoate , on hepatic aromatase activity in adult male CrlCD BR rats. Fundamental & Applied Toxicology 30(2): 220-228, 1996

Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha. Toxicology 265(1-2): 27-33, 2009

Role of peroxisome proliferator-activated receptor-alpha in hepatobiliary injury induced by ammonium perfluorooctanoate in mouse liver. Industrial Health 48(1): 96-107, 2010

Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO). Toxicology 225(2-3): 195-203, 2006

Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats. Toxicology 62(3): 321-332, 1990

Induction of hepatic aromatase by p,p'-DDE in adult male rats. Molecular and Cellular Endocrinology 178(1/2): 207-214, 2001

Aromatase-deficient (ArKO) mice are retrieved from severe hepatic steatosis by peroxisome proliferator administration. Hepatology Research 22(4): 278-287, 2002

Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats. Toxicology. 126(1): 65-73,. 20, 1998

Effect on the expression of C-met, c-myc, and peroxisome proliferator-activated receptor in liver and liver tumors of rats from chronic exposure to the hepatocarcinogenic peroxisome proliferator WY-14,643. Toxicologic Pathology 23(6): 759, 1995

13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats. Drug and Chemical Toxicology 27(4): 361-378, 2004

Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induced hepatic peroxisome proliferation in Sprague-Dawley rats. Biochimica et Biophysica Acta 1436(3): 331-342, Jan 4, 1999